Tag: GCP non-compliance

Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance In the realm of registrational clinical trials, ensuring compliance with the protocol is critical to both participant safety and the integrity of the collected data. Non-compliance can not only result in wasted resources but can also jeopardize the overall success of…

Read More “Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance” »

Regulatory Expectations for Realistic, Implementable Protocols In the dynamic landscape of clinical research, organizations must navigate a complex array of regulations and best practices to ensure compliance while conducting effective clinical trials. This tutorial offers a structured approach to understanding the regulatory expectations for realistic and implementable protocols, focusing on key lessons learned from protocol…

Read More “Regulatory Expectations for Realistic, Implementable Protocols” »

Aligning Feasibility Judgments With Patient Burden and Recruitment Goals Aligning Feasibility Judgments With Patient Burden and Recruitment Goals Clinical trials are essential for advancing medical knowledge and improving patient care. However, the success of these trials often hinges on meticulous planning and alignment with patient needs. This article outlines a detailed, step-by-step guide for clinical…

Read More “Aligning Feasibility Judgments With Patient Burden and Recruitment Goals” »

Documenting Lessons Learned From Deviation Experience for Future Programs In the realm of clinical research, the potential for protocol deviations is an ever-looming challenge that can significantly impact the outcome of a phase 3b clinical trial. Deviation experiences offer invaluable insights that, when documented effectively, can enhance future program execution. This article serves as a…

Read More “Documenting Lessons Learned From Deviation Experience for Future Programs” »

Integrating Feasibility Insights Into Country and Site Selection Integrating Feasibility Insights Into Country and Site Selection In the landscape of the future of clinical trials, the integration of feasibility insights into country and site selection is paramount. Understanding the intricate nuances of how these elements correlate can enhance not only protocol adherence but also improve…

Read More “Integrating Feasibility Insights Into Country and Site Selection” »

Using Simulation and Scenario Testing to Anticipate Deviation Risks Using Simulation and Scenario Testing to Anticipate Deviation Risks Clinical trials are fraught with uncertainties and risks, necessitating robust methodologies that ensure compliance with regulatory standards while optimizing the feasibility of study protocols. Utilizing simulation and scenario testing can significantly aid in anticipating potential deviations and…

Read More “Using Simulation and Scenario Testing to Anticipate Deviation Risks” »

Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels Introduction to Protocol Deviations in Clinical Trials In the realm of clinical research, protocol deviations are among the critical factors that can impact the integrity and reliability of clinical trial data. A protocol deviation occurs when there…

Read More “Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels” »

Cross-Functional Feasibility Reviews Focused on Deviation Prevention Cross-Functional Feasibility Reviews Focused on Deviation Prevention Introduction to Feasibility Reviews in Pharma Clinical Trials Feasibility reviews are essential components of the clinical trial planning process, especially within the pharmaceutical industry. These reviews gather insights from multiple departments—clinical operations, regulatory affairs, and medical affairs—to assess the practical aspects…

Read More “Cross-Functional Feasibility Reviews Focused on Deviation Prevention” »